Skip to content

Measurement of the levels of Mercury and Arsenic in blood and urine of psoriasis patient prescribed with Arogyavardhini vati and Rasamanikya

An Observational study to assess the levels of Mercury and Arsenic in the patients of Kitibhakushtha receiving Arogyavardhini vati and Rasamanikya - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/083603
Enrollment
49
Registered
2025-03-27
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L408- Other psoriasis

Interventions

None listed

Sponsors

AIIA Director
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Duration: Up to 10 years chronicity Patients of Plaque Psoriasis Patients having the clinical features of Kitibhakushtha (mild to moderate Psoriasis) with PASI score up to 10, BSA up to 3 %) Patients not taking any other Ayurvedic intervention in the last 6 months. Fresh cases of Kitibhakushtha on prescribtion of Arogyavardhini Vati and Rasamanikya along with Sidharthaka yoga lotion.

Exclusion criteria

Exclusion criteria: Patients with severe systemic disorders. Uncontrolled hypertension, Cardiac diseases, Diabetes mellitus. Pregnant Women and lactating mothers. Severe cases of Psoriasis Patients who are under the Ayurvedic treatment with other formulations

Design outcomes

Primary

MeasureTime frame
1. To assess the levels of mercury and arsenic levels in serum and urine samples of Kitibhakushtha patients during and post-intervention of study drugs Timepoint: baseline and after 12 weeks

Secondary

MeasureTime frame
To evaluate the safety of Arogyavardhini Vati & Rasamanikya along with Sidharthaka Yoga Lotion based on kidney injury biomarkers Timepoint: baseline & after 12 weeks

Countries

India

Contacts

Public ContactDr Jha Mohan Yogendra

All India Institue of Ayurveda

drpramod88@gmail.com7208490355

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026